tm logo
SIEN-NET
Live/Registered
REGISTERED

on 19 Jan 2021

Last Applicant/ Owned by

C/- BARD1 Life Sciences Ltd,

AU

Serial Number

79274546 filed on 08th Nov 2019

Registration Number

6248001 registered on 19th Jan 2021

in the Principal Register

Correspondent Address

Charles G. Zug

Nelson Mullins Riley & Scarborough LLP

Suite 2300, IP Department

301 S. College St.

Charlotte NC 28202

Filing Basis

No Filing Basis

Disclaimer

NO DATA

SIEN-NET

Pharmaceutical preparations and substances for the treatment and/or diagnosis of cancer and infectious diseases; biotechnologically-formed enzyme preparations for medical purposes; medicinal preparations for the treatment of cancer and infectious diseases; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarilRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for the treatment and/or diagnosis of cancer and infectious diseases; biotechnologically-formed enzyme preparations for medical purposes; medicinal preparations for the treatment of cancer and infectious diseases; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies used in the capture of specific biological markers for use in disease testing; proteins for binding antibodies for medical use; proteins for detecting antibodies for medical use; reagents for medical use, namely, for use in the development of monoclonal antibodies; diagnostic biomarker reagents for medical purposes; tagged antibodies for medical use; vaccines; vaccines against cancer, viral, and bacterial infection; vaccines for human use; diagnostic preparations and reagents for medical purposes; vaccine adjuvants; diagnostic preparations, reagents, and substances for medical purposes; diagnostic products and testing materials for medical purposes, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in capturing and purifying specific biological markers for use in disease testing; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents for capturing and purifying specific biological markers that can be utilised in therapeutics or diagnostics; cells for growing recombinant human protein for medical purposes; recombinant DNA technology proteins for medical use; biological reagents for use in molecular biology, namely, reagents for medical use for capturing and purifying specific biological markers that contain nucleic acid; antibodies that are specifically able to bind and capture specific biological markers for medical purposes; antibody fragments that are specifically able to bind and capture specific biological markers for medical purposes; antibody conjugates that are specifically able to bind and capture specific biological markers for medical purposes; pharmaceutical preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use

Mark Details


Serial Number

No 79274546

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 065491/09000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th May 2021FINAL DECISION TRANSACTION PROCESSED BY IB
23rd Apr 2021FINAL DISPOSITION NOTICE SENT TO IB
23rd Apr 2021FINAL DISPOSITION PROCESSED
19th Apr 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29th Jan 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
19th Jan 2021REGISTERED-PRINCIPAL REGISTER
03rd Nov 2020PUBLISHED FOR OPPOSITION
03rd Nov 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02th Nov 2020NOTIFICATION PROCESSED BY IB
14th Oct 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB